Pathophysiology of Heart Failure

Introduction

Heart failure develops when the heart is unable to meet the metabolic demands of the body. Adaptive changes such as ventricular hypertrophy initially help maintain cardiac output, but persistent pressure or volume overload eventually leads to ventricular dysfunction, chamber remodeling, and progressive circulatory failure.

Definition and Types

Definition

• Heart failure is a clinical syndrome in which the heart is unable to pump sufficient blood to meet the metabolic demands of body tissues.
• It does not imply sudden cardiac arrest or imminent death; rather, it reflects impaired cardiac performance.
• Heart failure commonly results from reduced myocardial contractility, persistent pressure overload, or chronic volume overload.
• Conditions such as hypertension, valvular heart disease, and myocardial infarction frequently lead to heart failure.
• A major physiological consequence is a reduction in stroke volume, resulting in inadequate forward flow of blood to tissues.
• In addition, impaired ventricular pumping causes accumulation of blood within the venous circulation, producing venous congestion.
• Forward failure refers to diminished cardiac output and inadequate tissue perfusion.
• Backward failure refers to venous pooling and elevated venous pressure.
• In most patients, both forward and backward components coexist because they arise from the same underlying defect—an inability of the heart to ntain effective circulation.

Types of Heart Failure

• Heart failure can be classified according to its onset, the side of the heart involved, and the level of cardiac output.

Acute vs Chronic Failure

• Acute heart failure develops suddenly, commonly after acute myocardial infarction, acute valvular dysfunction, or severe arrhythmias.
• Abrupt reduction in cardiac output often causes marked hypotension and poor tissue perfusion.
• Peripheral edema is usually absent initially because fluid retention has not yet developed.
• Chronic heart failure evolves gradually in conditions such as cardiomyopathy or chronic valvular disease.
• Compensatory mechanisms may maintain arterial pressure, but persistent fluid retention leads to dependent edema.

Left-sided vs Right-sided Failure

• In left-sided heart failure, blood accumulates in the pulmonary circulation, producing pulmonary congestion.
• Common manifestations include dyspnea, orthopnea, and pulmonary edema.
• In right-sided heart failure, systemic venous congestion predominates.
• Patients typically present with elevated jugular venous pressure, hepatomegaly, ascites, and peripheral edema.

High Output vs Low Output Failure

• High-output heart failure occurs when cardiac output is increased but remains inadequate to satisfy excessive metabolic demands.
• Causes include severe anemia, hyperthyroidism, thiamine deficiency, arteriovenous fistula, and extensive Paget disease of bone.
• Low-output heart failure results from impaired myocardial contractility or reduced ventricular pumping capacity.

Forward vs Backward Failure

• In backward heart failure, impaired ventricular emptying causes accumulation of blood in the atrium and venous system proximal to the failing ventricle.
• Elevated venous pressure increases capillary hydrostatic pressure, leading to edema and venous congestion.
• In forward heart failure, reduced cardiac output results in inadequate tissue perfusion and tissue hypoxia.
• Decreased renal perfusion activates the renin-angiotensin-aldosterone system, promoting sodium and water retention.
• Fluid retention may contribute to edema even in forward failure.
• In clinical practice, forward and backward failure commonly coexist.

Systolic vs Diastolic Failure

• Systolic heart failure results from impaired myocardial contractility, causing reduced ventricular ejection and decreased cardiac output.
• Common causes include ischemic heart disease and dilated cardiomyopathy.
• Diastolic heart failure occurs when ventricular relaxation and filling are impaired despite relatively preserved contractility.
• Restrictive cardiomyopathy, hypertrophic cardiomyopathy, and myocardial infiltration disorders such as amyloidosis are important causes.
• Impaired ventricular filling reduces end-diastolic volume, thereby decreasing stroke volume and cardiac output.

Cardiac Changes in Heart Failure

• Cardiac remodeling in heart failure depends largely on whether the primary abnormality is pressure overload or volume overload.
• Initially, structural adaptations help maintain cardiac performance, but persistent overload ultimately results in ventricular dysfunction and heart failure.

Pressure Overload

• Pressure overload occurs when the ventricle pumps against increased resistance, as in systemic hypertension or aortic stenosis.
• Increased afterload stimulates development of concentric hypertrophy, characterized by increased ventricular wall thickness with relatively little enlargement of the chamber.
• According to Laplace’s law, ventricular wall stress is directly proportional to intraventricular pressure and chamber radius and inversely proportional to wall thickness.
• During the compensatory phase, increased wall thickness reduces wall stress and preserves ventricular systolic function.
• This adaptive hypertrophy initially maintains stroke volume and cardiac output.
• With persistent overload, ventricular dilatation gradually develops.
• Enlargement of the ventricular cavity increases wall stress despite hypertrophy.
• Excessive wall stress impairs myocardial contractility, decreases ejection performance, and eventually produces systolic heart failure.
• Progressive ventricular dilatation shifts the ventricular pressure-volume relationship, reducing ejection efficiency.

Volume Overload

• Volume overload occurs when the ventricle is exposed to chronically increased end-diastolic volume, as in valvular regurgitation or chronic fluid retention.
• Increased venous return elevates ventricular filling pressure and promotes chamber enlargement.
• Early adaptation involves ventricular dilatation, which accommodates the increased end-diastolic volume.
• Dilatation increases chamber radius and initially raises ventricular wall stress.
• Subsequently, the myocardium undergoes eccentric hypertrophy, characterized by simultaneous enlargement of the chamber and increased wall mass.
• This adaptation temporarily normalizes wall stress and maintains cardiac function.
• Continued volume overload eventually causes excessive ventricular dilatation and further elevation of wall stress.
• Chronic ventricular enlargement increases myocardial oxygen demand and reduces mechanical efficiency.
• Long-standing dilatation may also lead to myocardial fibrosis and reduced ventricular compliance.
• Impaired ventricular relaxation decreases diastolic filling and contributes to diastolic dysfunction.

Clinical Features

Dyspnea

• Dyspnea refers to the subjective sensation of breathlessness and is a common symptom of left-sided heart failure.
• Impaired left ventricular function increases pulmonary venous pressure, leading to pulmonary congestion and reduced gas exchange.
• In the early stages, patients experience exertional dyspnea because cardiac output cannot adequately meet increased metabolic demands during physical activity.
• As heart failure progresses, pulmonary congestion worsens and dyspnea may occur even at rest.
• Severe ventricular dysfunction can produce persistent breathlessness due to marked reduction in tissue oxygen delivery.

thopnea

• Orthopnea is breathlessness that occurs in the recumbent position and is relieved by sitting or standing upright.
• It is a characteristic feature of left-sided heart failure and indicates pulmonary venous congestion.
• When a patient lies down, blood from the lower limbs and abdominal veins redistributes to the thoracic circulation.
• This increases pulmonary venous and capillary pressures, thereby worsening pulmonary congestion.
• The supine position also reduces lung expansion because the diaphragm is displaced upward.
• Reduced lung volumes are further aggravated by conditions such as hepatomegaly or ascites.
• Patients often sleep with multiple pillows to reduce symptoms.

Paroxysmal Nocturnal Dyspnea

• Paroxysmal nocturnal dyspnea refers to sudden episodes of severe breathlessness and cough that awaken the patient from sleep.
• It usually occurs several hours after the patient has fallen asleep.
• During sleep, fluid redistribution and increased venous return elevate pulmonary capillary pressure.
• Increased hydrostatic pressure causes transudation of fluid into the pulmonary interstitium and alveoli.
• Depression of respiratory drive during sleep may further aggravate symptoms.
• Patients typically awaken with a sensation of choking or suffocation and often sit upright or walk around for relief.
• Symptoms improve rapidly in the upright posture because pulmonary vascular congestion decreases.
• Recurrent nocturnal episodes are suggestive of advanced left ventricular failure.

Fatigue (Weakness and Exercise Intolerance)

• Fatigue is a common manifestation of heart failure and results primarily from reduced cardiac output.
• Diminished cardiac output decreases oxygen delivery to skeletal muscles and other tissues.
• Inadequate tissue perfusion leads to generalized weakness, easy fatigability, and reduced exercise capacity.
• Patients often experience exercise intolerance, as the failing heart cannot sufficiently increase blood flow during physical activity.
• Early fatigue during exertion is therefore an important indicator of impaired cardiac function.

Edema in the Dependent Parts

• Dependent edema is a characteristic feature of congestive heart failure.
• In ambulatory patients, edema commonly appears in the ankles and feet, whereas bedridden patients often develop sacral edema.
•   Reduced cardiac output decreases renal perfusion, which activates the renin-angiotensin-aldosterone system.
• Increased aldosterone secretion promotes renal sodium and water retention, expanding extracellular fluid volume.
• Enhanced sympathetic activity causes renal vasoconstriction and reduces glomerular filtration rate, further decreasing sodium and water excretion.
• Impaired ventricular pumping also produces systemic venous congestion, increasing venous and capillary hydrostatic pressures.
• Elevated capillary hydrostatic pressure enhances movement of fluid from capillaries into the interstitial space, resulting in edema.
• Gravitational pooling of blood in dependent regions further increases hydrostatic pressure, making edema more prominent in these areas.

Hepatomegaly

• Hepatomegaly in heart failure results from chronic hepatic venous congestion.
• A tender, enlarged liver is a characteristic feature of right-sided heart failure and congestive cardiac failure.

Increased JVP

• Jugular venous pressure is elevated because increased right atrial pressure is transmitted to the systemic veins.
• Raised jugular venous pressure is one of the most reliable clinical signs of congestive heart failure.

Ascites

Ascites, the accumulation of free fluid within the peritoneal cavity, usually develops in advanced stages of right-sided or biventricular heart failure due to persistent systemic venous congestion.

Physiological Basis of Management

• The primary goals of heart failure management are to improve cardiac output, reduce congestion, and treat the underlying cause.
• Adequate rest reduces metabolic demand on the heart, lowers venous pressure, and alleviates symptoms of congestion.
• A sodium-restricted diet is recommended because reduced salt intake decreases fluid retention and edema.
• Diuretics promote renal excretion of sodium and water, thereby reducing extracellular fluid volume, venous return, and cardiac workload.
• Digitalis enhances myocardial contractility and improves cardiac output. It acts by inhibiting the sodium-potassium adenosine triphosphatase pump, increasing intracellular calcium concentration in cardiac muscle cells.
• Vasodilators reduce systemic vascular resistance and ventricular afterload, enabling the heart to eject blood more efficiently.
• Angiotensin-converting enzyme inhibitors decrease formation of angiotensin II, thereby reducing vasoconstriction, aldosterone secretion, and adverse cardiac remodeling.
• Angiotensin receptor blockers, such as losartan, inhibit the effects of angiotensin II on blood vessels and other target tissues.
• Identification and correction of precipitating factors, including hypertension, arrhythmias, valvular disease, or myocardial ischemia, are essential components of comprehensive heart failure management.